A case of sensory ataxic Guillain–Barré syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.